Coverart for item
The Resource Accelerating the development of new drugs and diagnostics : maximizing the impact of the cures acceleration network, Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Accelerating the development of new drugs and diagnostics : maximizing the impact of the cures acceleration network, Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Label
Accelerating the development of new drugs and diagnostics : maximizing the impact of the cures acceleration network
Title
Accelerating the development of new drugs and diagnostics
Title remainder
maximizing the impact of the cures acceleration network
Statement of responsibility
Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Contributor
Subject
Genre
Language
eng
Summary
This public workshop considered options and opportunities to maximize the usefulness and impact of the Cures Acceleration Network (CAN) program in order to advance translational sciences. The workshop objectives were to:1. Identify and catalog potential tools, methods, and approaches that hold promise for accelerating translational science.-- Consideration of such promising approaches will draw from the experiences of existing activities at other federal agencies related to the goals of CAN--for example, FDA, the U.S. Centers for Disease Control and Prevention (CDC), and the Agency for Healthcare Research and Quality (AHRQ).2. Discuss the authorities conferred to CAN and identify strategies for effectively using those authorities.-- Consideration of the CAN authorities will specifically explore the flexible research, or "other transaction," authority and will reference existing efforts in which such authority is currently applied across other federal agencies--for example, DARPA, the Defense Threat Reduction Agency (DTRA), and the Biomedical Advanced Research and Development Authority (BARDA).3. Explore promising models for public-private collaborations that could be strengthened or facilitated by activities under CAN.-- Discuss barriers to such collaborations and identify opportunities and potential solutions for moving past the identified barriers.-- Discuss the respective roles of multiple sectors, including, for example, the pharmaceutical and biotechnology industries, venture capital and private equity, and patient advocacy groups.4. Identify barriers and potential solutions to facilitate coordination of activities under CAN with the FDA regulatory review process and timelines
Member of
Cataloging source
NLM
Dewey number
615.1/9
Funding information
This study was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (Contract Nos. N01-OD-4-2139 and HHSF223001003T), Abbott Pharmaceuticals, American Diabetes Association, American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, Bristol-Myers Squibb, Burroughs Wellcome Fund, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co., FasterCures, Foundation for the NIH, Friends of Cancer Research, GlaxoSmithKline, Janssen Research & Development, LLC, March of Dimes Foundation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc.
Index
no index present
LC call number
RS420
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
  • technical reports
NLM call number
QV 745
http://library.link/vocab/relatedWorkOrContributorDate
1956-
http://library.link/vocab/relatedWorkOrContributorName
  • Olson, Steve
  • Claiborne, Anne B
  • Institute of Medicine (U.S.)
http://library.link/vocab/subjectName
  • Drugs
  • Drug Discovery
  • Diagnostic Techniques and Procedures
  • MEDICAL
  • Drugs
  • United States
Label
Accelerating the development of new drugs and diagnostics : maximizing the impact of the cures acceleration network, Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Instantiates
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction -- Approaches to accelerating translational science -- Application of matching authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN
Control code
829421146
Dimensions
unknown
Extent
1 online resource (1 PDF file (xv, 115 pages))
Form of item
online
Isbn
9780309261173
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)829421146
Label
Accelerating the development of new drugs and diagnostics : maximizing the impact of the cures acceleration network, Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction -- Approaches to accelerating translational science -- Application of matching authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN
Control code
829421146
Dimensions
unknown
Extent
1 online resource (1 PDF file (xv, 115 pages))
Form of item
online
Isbn
9780309261173
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
System control number
(OCoLC)829421146

Library Locations

  • Ellis LibraryBorrow it
    1020 Lowry Street, Columbia, MO, 65201, US
    38.944491 -92.326012
  • Engineering Library & Technology CommonsBorrow it
    W2001 Lafferre Hall, Columbia, MO, 65211, US
    38.946102 -92.330125
  • Fisher Delta Research CenterBorrow it
    2-64 Agricultural Bldg, Columbia, MO, 65201, US
    38.958397 -92.303491
  • Geological Sciences LibraryBorrow it
    201 Geological Sciences, Columbia, MO, 65211, US
    38.947375 -92.329062
  • J. Otto Lottes Health Sciences LibraryBorrow it
    1 Hospital Dr, Columbia, MO, 65201, US
    38.939544 -92.328377
  • Journalism LibraryBorrow it
    102 Reynolds Jrnlism Institute, Columbia, MO, 65211, US
    38.947290 -92.328025
  • Mathematical Sciences LibraryBorrow it
    104 Ellis Library, Columbia, MO, 65201, US
    38.944377 -92.326537
  • University ArchivesBorrow it
    Columbia, MO, 65201, US
  • University Archives McAlester AnnexBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
    38.934630 -92.342290
  • University of Missouri Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65211, US
    38.919360 -92.291620
  • Zalk Veterinary Medical LibraryBorrow it
    Veterinary Medicine West, Columbia, MO, 65211, US
    38.941099 -92.317911
Processing Feedback ...